• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

晚期胰腺癌介入治疗临床实践指南（第5版）

Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5 edition).

作者信息

Li Maoquan

机构信息

China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot, China.

Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch, China.

出版信息

J Interv Med. 2021 Aug 14;4(4):159-171. doi: 10.1016/j.jimed.2021.08.001. eCollection 2021 Nov.

DOI:10.1016/j.jimed.2021.08.001
PMID:35586384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8947992/
Abstract

Pancreatic cancer has become a major disease affecting people's health because of its insidiousness, rapid progression and poor prognosis. Based on the practical needs of clinical work, combined with domestic multi-center research and experience, this guideline provides constructive suggestions for the interventional treatment of pancreatic cancer.

摘要

胰腺癌因其隐匿性、进展迅速和预后较差，已成为影响人们健康的主要疾病。本指南基于临床工作的实际需求，结合国内多中心研究和经验，为胰腺癌的介入治疗提供建设性建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67f0/8947992/ccd1bec45175/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67f0/8947992/c46d91dc8211/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67f0/8947992/ccd1bec45175/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67f0/8947992/c46d91dc8211/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67f0/8947992/ccd1bec45175/gr2.jpg

相似文献

1
Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5 edition).晚期胰腺癌介入治疗临床实践指南（第5版）
J Interv Med. 2021 Aug 14;4(4):159-171. doi: 10.1016/j.jimed.2021.08.001. eCollection 2021 Nov.
2
In advanced pancreatic cancer: The value and significance of interventional therapy.在晚期胰腺癌中：介入治疗的价值与意义。
J Interv Med. 2020 Jul 9;3(3):118-121. doi: 10.1016/j.jimed.2020.07.002. eCollection 2020 Sep.
3
[Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version)].《胰腺癌诊疗综合指南（2020年版）》
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):81-100. doi: 10.3760/cma.j.cn112139-20201113-00794.
4
Tumor size classification of the 8 edition of TNM staging system is superior to that of the 7 edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy.第八版 TNM 分期系统的肿瘤大小分类在预测胰腺癌患者根治性切除术后辅助化疗的生存结局方面优于第七版。
Sci Rep. 2018 Jul 10;8(1):10383. doi: 10.1038/s41598-018-28193-4.
5
Validation of American Joint Committee on Cancer 8 edition of TNM staging in resected distal pancreatic cancer.美国癌症联合委员会第8版TNM分期在可切除性远端胰腺癌中的验证
World J Gastrointest Pharmacol Ther. 2020 Jun 9;11(2):25-39. doi: 10.4292/wjgpt.v11.i2.25.
6
Magnetic resonance imaging for preoperative staging of pancreatic cancer based on the 8 edition of AJCC guidelines.基于美国癌症联合委员会（AJCC）第8版指南的胰腺癌术前分期磁共振成像
J Gastrointest Oncol. 2020 Apr;11(2):329-336. doi: 10.21037/jgo.2020.03.06.
7
[Evaluation of American Joint Commission on Cancer(8 edition) and Japanese Pancreas Society(7 edition)changes for T and N staging in patients with pancreatic adenocarcinoma].[美国国立综合癌症网络（第8版）和日本胰腺学会（第7版）对胰腺腺癌患者T和N分期变化的评估]
Zhonghua Wai Ke Za Zhi. 2017 Jan 1;55(1):20-23. doi: 10.3760/cma.j.issn.0529-5815.2017.01.006.
8
Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8 edition of the American Joint Committee on Cancer staging system.肠系膜门静脉侵犯应成为胰腺导管腺癌 TNM 分期的一个重要因素：美国癌症联合委员会第 8 版分期系统的修改建议。
World J Gastroenterol. 2019 Dec 14;25(46):6752-6766. doi: 10.3748/wjg.v25.i46.6752.
9
[Comparison of the prognostic value of the seventh and eighth edition of for the patients with stage Ⅱ and Ⅲesophageal squamous cell carcinoma].[《第七版和第八版（相关内容）》对Ⅱ期和Ⅲ期食管鳞状细胞癌患者预后价值的比较] （原文中“第七和第八版”后面缺少具体内容，这里只能根据大概结构进行翻译，补充完整后会更准确）
Zhonghua Wai Ke Za Zhi. 2017 Dec 1;55(12):903-908. doi: 10.3760/cma.j.issn.0529-5815.2017.12.006.
10
[Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2018 version)].[胰腺癌诊断与治疗综合指南（2018年版）]
Zhonghua Wai Ke Za Zhi. 2018 Jul 1;56(7):481-494. doi: 10.3760/cma.j.issn.0529-5815.2018.07.001.

引用本文的文献

1
Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer.局部治疗与胰腺癌肿瘤微环境重塑
Int J Mol Sci. 2023 Aug 11;24(16):12681. doi: 10.3390/ijms241612681.
2
Complementary and alternative medicine mention and recommendations in pancreatic cancer clinical practice guidelines: A systematic review and quality assessment.胰腺癌临床实践指南中的补充和替代医学提及与推荐：一项系统综述与质量评估
Integr Med Res. 2023 Mar;12(1):100921. doi: 10.1016/j.imr.2023.100921. Epub 2023 Jan 5.
3
Nardoguaianone L Isolated from Improved the Effect of Gemcitabine Chemotherapy via Regulating AGE Signaling Pathway in SW1990 Cells.

本文引用的文献

1
Analysis of the efficacy of transcatheter arterial infusion chemotherapy in the treatment of pancreatic carcinoma.经导管动脉灌注化疗治疗胰腺癌的疗效分析
J Interv Med. 2020 Oct 17;4(1):21-26. doi: 10.1016/j.jimed.2020.10.005. eCollection 2021 Feb.
2
In advanced pancreatic cancer: The value and significance of interventional therapy.在晚期胰腺癌中：介入治疗的价值与意义。
J Interv Med. 2020 Jul 9;3(3):118-121. doi: 10.1016/j.jimed.2020.07.002. eCollection 2020 Sep.
3
The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial.
纳曲酮 L 从改善吉西他滨化疗的效果通过调节 AGE 信号通路在 SW1990 细胞。
Molecules. 2022 Oct 13;27(20):6849. doi: 10.3390/molecules27206849.
病理方法及切缘定义在壶腹周围癌胰十二指肠切除术后切缘状态评估中的作用。一项多中心前瞻性随机试验的结果
Cancers (Basel). 2021 Apr 26;13(9):2097. doi: 10.3390/cancers13092097.
4
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.局部进展期胰腺癌的经皮治疗：消融、近距离放疗、动脉内化疗和瘤内免疫治疗。
Curr Oncol Rep. 2021 Apr 17;23(6):68. doi: 10.1007/s11912-021-01057-3.
5
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.胰腺导管腺癌临床实践指南（第 2.2021 版），NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017.
6
Locally advanced pancreatic carcinoma with jaundice: the benefit of a sequential treatment with stenting followed by CT-guided I seeds implantation.伴有黄疸的局部进展期胰腺癌：支架置入序贯 CT 引导下 125I 粒子植入治疗的获益。
Eur Radiol. 2021 Sep;31(9):6500-6510. doi: 10.1007/s00330-021-07764-6. Epub 2021 Feb 25.
7
Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database.新辅助治疗与T1和T2期胰头癌行胰十二指肠切除术后切缘阳性率较低相关：一项基于国家癌症数据库的分析
Surg Open Sci. 2020 Dec 16;3:22-28. doi: 10.1016/j.sopen.2020.12.001. eCollection 2021 Jan.
8
[Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version)].《胰腺癌诊疗综合指南（2020年版）》
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):81-100. doi: 10.3760/cma.j.cn112139-20201113-00794.
9
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021.胰腺癌辅助治疗管理：2021年的新展望
Cancers (Basel). 2020 Dec 21;12(12):3866. doi: 10.3390/cancers12123866.
10
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.CA19-9 的时间轨迹作为胰腺癌早期检测的锚定标志物。
Gastroenterology. 2021 Mar;160(4):1373-1383.e6. doi: 10.1053/j.gastro.2020.11.052. Epub 2020 Dec 14.